EXPLEOSOL880.00

Expleo Solutions Limited

· Technology
₹ CrorePeersDSSLDIGITIDECEINSYSIZMOORIENTTECHAURUMBCGGENESYSMcap ₹1,366 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Receivable Days (DSO)94.3379.1875.6275.62
Payable Days (DPO)2,027.202,980.561,437.781,284.90
Cash Conversion Cycle (days)-1,932.87-2,901.38-1,362.16-1,209.28
Working Capital Turnover1.952.451.901.95
Asset Turnover1.261.231.191.19
Cash Conversion (CFO/Net Income)0.791.740.960.96
CFO/EBITDA0.481.080.700.70
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.